Table 3 Multivariable logistic regression analysis for postoperative delirium in patients undergoing cardiac surgery.
Unadjusted model | Adjusted model | |||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Intraoperative pupillometry | ||||
NPi ≥ 3.0 | Ref | Ref | ||
NPi < 3.0 | 2.653 (1.032–6.817) | 0.043 | 6.078 (1.845–20.025) | 0.003 |
Baseline characteristics | ||||
Age | 1.069 (1.016–1.126) | 0.011 | ||
Male | 1.358 (0.553–3.339) | 0.505 | ||
Body mass index | 0.976 (0.859–1.110) | 0.716 | ||
Hematocrit | 0.908 (0.836–0.987) | 0.024 | ||
STS-PROM | 1.410 (1.163–1.710) | < 0.001 | 1.566 (1.218–2.013) | < 0.001 |
LV EF | 0.960 (0.922–1.001) | 0.053 | ||
Comorbidity | ||||
Hypertension | 1.206 (0.493–2.950) | 0.682 | ||
Diabetes mellitus | 1.429 (0.573–3.559) | 0.444 | ||
Coronary artery disease | 2.259 (0.915–5.578) | 0.077 | 6.421 (1.839–22.426) | 0.004 |
Previous MI or angina | 1.361 (0.502–3.684) | 0.545 | ||
Chronic kidney disease | 3.625 (1.279–10.270) | 0.015 | ||
Preoperative atrial fibrillation | 3.379 (1.347–8.477) | 0.009 | ||
Previous stroke or TIA | 2.275 (0.624–8.299) | 0.213 | ||
Chronic obstructive pulmonary disease | 2.214 (0.512–9.578) | 0.287 | ||
Preoperative medication | ||||
ACEi or ARB | 0.664 (0.266–1.659) | 0.381 | ||
Beta blocker | 0.800 (0.328–1.954) | 0.624 | ||
Calcium channel blocker | 0.471 (0.185–1.200) | 0.114 | 0.257 (0.077–0.857) | 0.027 |
Diuretics | 2.500 (0.980–6.379) | 0.055 | ||
Statin | 0.705 (0.287–1.735) | 0.447 | ||
Benzodiazepine | 3.760 (0.927–15.256) | 0.064 | ||
Intraoperative variables | ||||
Duration of operation | 1.006 (1.001–1.011) | 0.024 | ||
Use of cardiopulmonary bypass | 0.960 (0.342–2.694) | 0.938 | ||
Type of surgery | 0.895 | |||
CABG | Ref | |||
Valve surgery | 0.820 (0.306–2.274) | 0.699 | ||
Aorta surgery | 0.208 (0.002–2.040) | 0.330 | ||
Combined surgery* | 0.678 (0.114–2.971) | 0.638 | ||
Other cardiac surgery† | 0.917 (0.151–4.225) | 0.919 | ||
Redo surgery | 2.993 (0.882–10.158) | 0.079 | ||
Lowest core body temperature | 1.035 (0.913–1.173) | 0.588 | ||
Lowest bispectral index | 0.993 (0.961–1.027) | 0.689 | ||
Moderate desaturation of cerebral oximeter | 1.750 (0.662–4.626) | 0.259 | ||
Severe desaturation of cerebral oximeter | 3.393 (0.706–16.305) | 0.127 | ||
Total amount of infused remifentanil | 1.000 (1.000–1.000) | 0.807 | ||
Intraoperative transfusion | 2.824 (1.034–7.710) | 0.043 | ||
Intraoperative use of inotropic or vasoactive agent | ||||
Epinephrine | 2.000 (0.560–7.147) | 0.286 | ||
Norepinephrine | 1.429 (0.442–4.619) | 0.551 | ||
Dobutamine | 1.500 (0.544–4.135) | 0.433 | ||
Nitroglycerin | 1.506 (0.603–3.764) | 0.381 | ||
Postoperative use of benzodiazepine | 6.382 (1.909–21.334) | 0.003 |